SpringLeaf Therapeutics Inc.
Industry
- Medical Devices
- Pharmaceuticals
- Drug Delivery
- Biotechnology
Latest on SpringLeaf Therapeutics Inc.
The strong flow of initial public offerings by life sciences companies has not abated yet, as six biopharma companies filed S-1 registrations with the Securities and Exchange Commission or priced prev
Start-Up Execs Caprotec bioanalytics GMBH Jonathan Turner, PhD To:Managing Dir. & CEO (October) From:SVP, XL Techgroup Tel:+49 30 63 92 39 90 Cebix Inc. Joel Martin, PhD To:Pres. & CEO (October)
A look at financing, M&A, and alliance activity April–June 2011 In this issue, we present another installment of our quarterly review of pharmaceutical/biotechnology dealmaking – for the second quarte
In Vitro Diagnostics KellBenx Inc. Seed funding brings in $2.4mm for KellBenx KellBenx Inc. (noninvasive prenatal diagnostics for genetic disorders) has raised $2.4mm through its seed round. Of th